CVS Health chairman David Dorman on healthcare's hybrid future
David Dorman is no stranger to being in the captain’s chair amid a crisis. Previously the CEO at storied telecommunications firm AT&T, Dorman shepherded the firm through the disruption to the industry in the early 2000s. He repositioned the firm in a rapidly modernizing environment and ultimately delivered on selling the firm in 2005 for $16 billion. Today Dorman is the chairman of CVS Health, a firm that owns a network of retail locations within a 10-minute drive of 85% of the U.S. population. The pharmacy has played a crucial role in improving Americans’ collective health during the pandemic, delivering more than 41 million COVID-19 tests and more than 50 million vaccines. In addition to its vaccine delivery program, CVS Health has accelerated its digital initiatives to push out services through mobile apps and websites. It further integrated Aetna, a health insurance firm it acquired in 2019 and launched a new virtual care platform with the brand. It also furthered its corporate social responsibility strategy, “Transform Health 2030” and took the lead in mandating vaccines for its own frontline staff. A special interview with CVS Health Chairman David Dorman, joined by Info-Tech Research Group Research Fellow Ken McGee.